Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD
- PMID: 31222861
- DOI: 10.1111/resp.13620
Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD
Abstract
Background and objective: Acute exacerbations in chronic obstructive pulmonary disease (COPD) may trigger major adverse cardiac events (MACE). We aimed to determine whether the risk of having MACE was transiently increased following the onset of an acute COPD exacerbation.
Methods: We conducted a nationwide, register-based study from 1997 to 2014 comprising individuals with an acute COPD exacerbation followed by a MACE (acute myocardial infarction (MI), stroke or cardiovascular death). Using the case-crossover design, we estimated odds ratios (OR) for the association between acute exacerbations of COPD and MACE as well as for single outcomes (acute MI, stroke and cardiovascular death), different levels of severity of exacerbations and within patient subgroups.
Results: We identified 118 807 cases with a MACE preceded by an exacerbation. Overall, the risk of MACE increased almost fourfold following the onset of an acute exacerbation compared to periods without exacerbations in the same individuals (OR: 3.70; 95% CI: 3.60-3.80). The associations were consistent for single outcomes (acute MI, OR: 3.57; cardiovascular death, OR: 4.33; and stroke, OR: 2.78) and particularly strong associations were demonstrated for severe exacerbations (OR: 5.92) and the oldest individuals (OR: 4.18).
Conclusion: The risk of MACE increased substantially following the onset of an acute exacerbation. This highlights that prevention of cardiac events is an important goal in the management of COPD. Attention should be paid to detecting cardiovascular disease following acute COPD exacerbations.
Keywords: acute chronic obstructive pulmonary disease exacerbations; chronic obstructive pulmonary disease; epidemiological studies; myocardial infarction; stroke.
© 2019 Asian Pacific Society of Respirology.
Comment in
-
COPD exacerbations and MACE: More than a chance encounter?Respirology. 2019 Dec;24(12):1129-1130. doi: 10.1111/resp.13683. Epub 2019 Aug 21. Respirology. 2019. PMID: 31432595 No abstract available.
References
REFERENCES
-
- Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir. Med. 2013; 1: 73-83.
-
- Zielinski J, MacNee W, Wedzicha J, Ambrosino N, Braghiroli A, Dolensky J, Howard P, Gorzelak K, Lahdensuo A, Strom K et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch. Chest Dis. 1997; 52: 43-7.
-
- Jensen HH, Godtfredsen NS, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur. Respir. J. 2006; 28: 781-5.
-
- Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD 2010; 7: 375-82.
-
- Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur. Respir. J. 2006; 28: 1245-57.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
